Sanofi SA (ADR) (NYSE:SNY)’s Shan5 Regains WHO Prequalification Status

Boston, MA 05/06/2014 (wallstreetpr) – After four years of disqualification, Sanofi SA (ADR) (NYSE:SNY)‘s five-in-one vaccine, dubbed Shan5, for children is granted prequalification status by the World Health Organization (WHO). Re-Opens Door For UN Agencies The prequalification status will open up the sale of the vaccine to the United Nations agencies like UNICEF and will […]